首页> 外国专利> New monoclonal antibody specific for aurora-A kinase, useful for diagnosis, prognosis and treatment of solid tumors, also for drug screening

New monoclonal antibody specific for aurora-A kinase, useful for diagnosis, prognosis and treatment of solid tumors, also for drug screening

机译:特异性针对Aurora-A激酶的新型单克隆抗体,可用于实体瘤的诊断,预后和治疗,也可用于药物筛选

摘要

Monoclonal antibody (MAb) that recognizes specifically the human or murine aurora-A kinase (I) binds to membranes that contain (I), can detect and optionally purify (I) by immunoprecipitation, stains biological tissues where (I) is secreted and does not inhibit the enzymatic activity of (I), is new. Independent claims are also included for the following: (1) in vitro diagnosis and prognosis of solid tumors (of breast, stomach or colon-rectum) in humans or animals, using MAb to detect, and optionally quantify, (I) in biological samples; (2) kit for performing method (1), comprising MAb and optionally a marker of cell proliferation, preferably a marker of PCNA, especially an antibody; (3) screening for inhibitors of (I); and (4) preparing MAb.
机译:特异性识别人或鼠源极光A激酶(I)与包含(I)的膜结合的单克隆抗体(MAb),可以通过免疫沉淀法检测并可选地纯化(I),对其中(I)分泌的生物组织染色并能不抑制(I)的酶活性,是新的。还包括以下方面的独立权利要求:(1)使用MAb检测并可选地量化(I)生物样品中人或动物实体瘤(乳腺,胃或结肠直肠结肠瘤)的体外诊断和预后; (2)用于执行方法(1)的试剂盒,其包含MAb和任选的细胞增殖标志物,优选PCNA标志物,尤其是抗体; (3)筛选(I)的抑制剂; (4)制备单克隆抗体。

著录项

  • 公开/公告号FR2840905A1

    专利类型

  • 公开/公告日2003-12-19

    原文格式PDF

  • 申请/专利号FR20020007212

  • 发明设计人 PRIGENT CLAUDE;MARTIN ANNE;

    申请日2002-06-12

  • 分类号C07K16/32;C07K16/40;G01N33/577;G01N33/574;G01N33/573;A61K39/395;A61P35/00;

  • 国家 FR

  • 入库时间 2022-08-21 22:39:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号